Eton Pharmaceuticals Inc. (NASDAQ: ETON) Stock Information | RedChip

Eton Pharmaceuticals Inc. (NASDAQ: ETON) Listen to this Section


$4.03
+0.0200 ( +0.50% ) 45.6K

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Market Data


Open


$4.03

Previous close


$4.01

Volume


45.6K

Market cap


$104.12M

Day range


$3.98 - $4.23

52 week range


$3.03 - $5.81

Insider Ownership Transactions

Total Amount Purchased: -847,987.00 | $ -3,417,387.61

Date Type Amount Purchased Purchaser
2024-02-15 Sale -30000.00 RIEDEL NORBERT G
2024-02-15 Sale -30000.00 MAIER PAUL V
2024-02-15 Sale -144677.00 Krempa David
2024-02-15 Sale -30000.00 CASAMENTO CHARLES J
2024-02-15 Sale -438633.00 BRYNJELSEN SEAN
2024-02-15 Sale -30000.00 Adams Jennifer McKie
2024-02-15 Sale -144677.00 Gruber James R.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 08, 2024
10-q Quarterly Reports 61 Aug 08, 2024
8-k/a 8K-related 14 Aug 02, 2024
8-k 8K-related 15 Jul 15, 2024
8-k 8K-related 15 Jun 21, 2024
8-k 8K-related 14 Jun 11, 2024
10-q Quarterly Reports 60 May 09, 2024
8-k 8K-related 15 May 09, 2024
8-k 8K-related 15 Apr 30, 2024
def Proxies and info statements 21 Apr 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.